Foundations and Research Decisions

Foundations and Research Decisions Regarding Susan M. Fitzpatrick's opinion article,1 we agree that many other private foundations have made, and continue to make, important contributions to research on the diseases of the developing world. In fact, we have consulted extensively with several of these foundations during the process of designing the Grand Challenges initiative. We take issue, however, with Dr. Fitzpatrick's claim that the initiative relies "on [National Institutes of Health

Written byRichard Klausner
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Regarding Susan M. Fitzpatrick's opinion article,1 we agree that many other private foundations have made, and continue to make, important contributions to research on the diseases of the developing world. In fact, we have consulted extensively with several of these foundations during the process of designing the Grand Challenges initiative.

We take issue, however, with Dr. Fitzpatrick's claim that the initiative relies "on [National Institutes of Health] leadership and decision-making." While the initiative is administered by the NIH Foundation, all grant decisions will be made by an independent board of leading scientific experts, including several researchers from the developing world. Of the 20 members of this board, only two or three are part of NIH. In addition, the initiative will be carried out in partnership with other international research institutions as it evolves.

While the Gates Foundation believes strongly in the importance of collaborating with the private sector, governments, and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies